Coordination Pharmaceuticals Inc. — Form D
Coordination Pharmaceuticals Inc. of ELK GROVE VILLAGE, IL, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-14. The offering totals $22.0M, of which $18.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-09-14
- Form: D
- Accession: 0001882811-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $22.0M
- Amount sold: $18.0M
- Remaining: $4.0M
- Minimum investment: $100K
- Investors: 4
- Date of first sale: 2021-08-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-413256
Issuer
- Name: Coordination Pharmaceuticals Inc.
- CIK: 0001882811
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1400 CHASE AVENUE, ELK GROVE VILLAGE, IL, 60007
- Phone: 6304155601
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Xiaochang Dai | Director | Elk Grove Village, IL |
| Wenbin Lin | Director | Elk Grove Village, IL |
| Jianhua Yang | Director | Elk Grove Village, IL |
| Ze-Qi Xu | Executive Officer | Elk Grove Village, IL |
More